Literature DB >> 21093490

Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors.

Julia J M Eekels1, Dirk Geerts, Rienk E Jeeninga, Ben Berkhout.   

Abstract

In this study we tested whether HIV-1 replication could be inhibited by stable RNAi-mediated knockdown of cellular co-factors. Cell lines capable of expressing shRNAs against 30 candidate co-factors implicated at different steps of the viral replication cycle were generated and analyzed for effects on cell viability and inhibition of HIV-1 replication. For half of these candidate co-factors we obtained knockdown cell lines that are less susceptible to virus replication. For three co-factors (ALIX, ATG16 and TRBP) the cell lines were resistant to HIV-1 replication for up to 2 months. With these cells we could test the hypothesis that HIV-1 is not able to escape from RNAi-mediated suppression of cellular co-factors, which was indeed not detected.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093490     DOI: 10.1016/j.antiviral.2010.11.005

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  30 in total

Review 1.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

Review 3.  Selection of RNAi-based inhibitors for anti-HIV gene therapy.

Authors:  Stefanie A Knoepfel; Mireille Centlivre; Ying Poi Liu; Fatima Boutimah; Ben Berkhout
Journal:  World J Virol       Date:  2012-06-12

4.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

5.  CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release.

Authors:  David O Ajasin; Vasudev R Rao; Xuhong Wu; Santhamani Ramasamy; Mario Pujato; Arthur P Ruiz; Andras Fiser; Anne R Bresnick; Ganjam V Kalpana; Vinayaka R Prasad
Journal:  Elife       Date:  2019-06-07       Impact factor: 8.140

6.  The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.

Authors:  E Herrera-Carrillo; B Berkhout
Journal:  Gene Ther       Date:  2015-02-26       Impact factor: 5.250

7.  A novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner.

Authors:  Ye Liu; Jieqiong Zhou; Ji-An Pan; Prudence Mabiala; Deyin Guo
Journal:  Mol Biotechnol       Date:  2014-10       Impact factor: 2.695

8.  Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.

Authors:  Jingmei Ye; Jiani Wang; Li Tan; Shaojiang Yang; Lihua Xu; Xiaohong Wu; Huaifu Deng; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 9.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

Review 10.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.